The German, Danish and Norwegian perspectives on clinical trials. Panel on 37 °C Life Science Technology Conference and Exhibition 6-7 June Stavanger

Screen Shot 2017-05-09 at 16.39.43.png

Anne Kjersti Fahlvik, Heiko von der Leyen, Britta Smedegaard Andersen, Birgitta Tunning

The panel will consist of Heiko von der Leyen (MD CEO of Hannover Clinical Trial Center), Britta Smedegaard Andersen (Project Director of the Danish NEXT project) and Anne Kjersti Fahlvik (Executive Director of the Division for Innovation at the Research Council of Norway). And be moderated by Birgitta Tunning (eHealth Unit Leader Nordics in IBM).

The panel discussion will cover the clinical trials aspects of market entry, comparing modus operandi in different countries Impact of new EU regulations; The role that clinical studies plays in sustaining and building industry; Impact of digital technology, AI and personalised medicine.

To Register, click here:

We are looking forward to seeing you on 37 °C in June!